|
Mar 7
|
Pharma Stock Roundup: BAYRY's Q4 Results, ABBV's Obesity Deal & More
|
|
Mar 7
|
This Could Be a Huge Blow to Hims & Hers Health Stock
|
|
Mar 7
|
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
|
|
Mar 6
|
Hims & Hers' Weight-Loss Bet Hits a Wall--Is the Stock's $6 Billion Surge About to Unravel?
|
|
Mar 6
|
Novo Nordisk Faces a Perfect Storm: Tariff Shock and Legal Battle Threaten Its Blockbuster Drugs
|
|
Mar 6
|
Even weight loss drugs aren't safe from tariffs
|
|
Mar 6
|
'For Novo Nordisk, I do not worry a lot about tariffs:' CEO Lars Jørgensen
|
|
Mar 6
|
Hims & Hers Stock Is Due for a Crash Diet. The Weight-Loss Drug Surge Is Fading Fast.
|
|
Mar 6
|
Novo Nordisk Lowers Wegovy Costs for Cash-Pay Patients, Stock Up 4%
|
|
Mar 6
|
Novo Nordisk cuts Wegovy price through new direct-to-patient online pharmacy
|
|
Mar 6
|
Company News for Mar 6, 2025
|
|
Mar 6
|
Tariff Uncertainty Is Crippling Stock Markets, but Trump’s Auto Move Offers Hope. And 5 Other Things to Know Today.
|
|
Mar 5
|
Why Novo Nordisk Stock Outpaced the Market Today and Hims & Hers Lagged It
|
|
Mar 5
|
Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy
|
|
Mar 5
|
GM, Novo Nordisk, Moderna, Marvell, CrowdStrike: Stocks to watch today
|
|
Mar 5
|
The Dow surges 500 points as Trump hands out some tariff relief
|
|
Mar 5
|
Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket
|
|
Mar 5
|
Novo Nordisk Shares Climb as Wegovy Price Slashed Over 50%
|
|
Mar 5
|
Top Midday Stories: CrowdStrike Shares Drop After EPS Outlook Misses Consensus; UK Antitrust Watchdog Clears Microsoft's OpenAI Partnership
|
|
Feb 22
|
Why Novo Nordisk A/S (NVO) Surged On Friday?
|